|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.42 USD | +0.23% |
|
-2.01% | -19.24% |
| Apr. 26 | TD Cowen Adjusts Price Target on Gilead Sciences to $85 From $90 | MT |
| Apr. 26 | Jefferies Adjusts Gilead Sciences' Price Target to $80 From $95 | MT |
U.S. SUPREME COURT REFUSES TO HEAR MERCK & CO BID TO REVIVE $2.5 BILLION PATENT INFRINGEMENT VERDICT AGAINST GILEAD SCIENCES INC OVER HEPATITIS C
| 1st Jan change | Capi. | |
|---|---|---|
| -19.24% | 81.39B | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B |
GILEAD SCIENCES, INC. 
